SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

S&P 100 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Biogen Idec Inc: Click to view the issuer\'s details

Last update : 21/08/2018  >View issuer details

2018.10.17 | 08:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union - HTML (w)

2018.10.11 | 13:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Biogen Advances Research to Improve Outcomes for Patients With Multiple Sclerosis - HTML (w)

2018.09.04 | 13:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Biogen Enrolls First Patient in Global Phase 3 Study of BIIB093 (IV Glibenclamide) for Large Hemispheric Infarction - HTML (w)

2018.07.24 | Periodic information / Half-Year Financial Report

English version PDF Mail

puce Biogen Idec Inc : Second quarter 2018 - PDF (376Kb)

2018.07.06 | 01:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months - HTML (w)

Pages : 1 - 2 - 3 / Doc nb : 36